MING XU: Open Payments
NPI 1548271018 · BOURBONNAIS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$116,917 in 138 payments from 7 companies in 2025. Trend: 2023 $103,529 · 2024 $97,996 · 2025 $116,917
Speaker / faculty: $79,878Honoraria: $21,450Travel & lodging: $7,135Consulting: $4,630Food & beverage: $3,825
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 39 | $31,765 |
| ABBVIE INC. | 22 | $23,858 |
| Axsome Therapeutics, Inc. | 24 | $23,086 |
| Alkermes, Inc. | 20 | $18,199 |
| Vanda Pharmaceuticals Inc. | 22 | $11,657 |
| Teva Pharmaceuticals USA, Inc. | 5 | $8,169 |
| Supernus Pharmaceuticals, Inc. | 6 | $183 |
Products named: COBENFY, VRAYLAR, Auvelity, LYBALVI, FANAPT, UZEDY, Qelbree.
Industry payments across IL — which companies pay providers there.
